GlassScriptPhysician profile
Jermaine A Joefield
NPI 1164505400
$821.16
in general payments reported to CMS, 2019-2025
17 companies · $70.87 in 2025
The $70.87 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $30.52 · 2022: $14.03 · 2023: $67.76 · 2024: $318 · 2025: $70.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $218.89 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $77.57 | 2019-2024 | Otezla, Repatha, Krystexxa |
| Astrazeneca Pharmaceuticals LP | $75.06 | 2019-2024 | Airsupra |
| Lilly USA, LLC | $62.46 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $43.83 | 2019 | |
| Sanofi-Aventis U.S. LLC | $43.02 | 2019 | |
| Abbvie INC. | $42.72 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $37.47 | 2024 | Keveyis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.52 | 2019 | |
| Glaxosmithkline, LLC. | $34.67 | 2023 | Trelegy Ellipta |
| Irhythm Technologies, INC. | $30.76 | 2024 | Zio Xt Patch, Zio Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.69 | 2019-2024 | Xifaxan |
| Dexcom, INC. | $23.69 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $23.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.03 | 2022 | |
| Exact Sciences Corporation | $13.70 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jermaine Joefield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.